Interplay Between Inter Partes Reviews (IPRs) And ITC Section 337 Proceedings 05/05/2017 by Guest contributor for Intellectual Property Watch Leave a Comment Since the passage of the America Invents Act (“AIA”) in 2011, Inter Partes Reviews (“IPRs”) before the Patent Trial and Appeal Board (“PTAB”) have assumed growing importance in patent litigation in federal district courts. Until recently, IPRs have not played a significant role in International Trade Commission (“ITC”) Section 337 investigations. While the ITC is unlikely to stay a Section 337 investigation, pending IPRs will likely have an increasing impact at the ITC, especially when an IPR proceeding reaches an advanced stage before or during the pendency of a Section 337 investigation. This article examines the limited interplay to date between IPRs and Section 337 proceedings and discusses potential implications for future investigations.
Paper: National Laws, UPOV, Should Be Revised To Ensure Farmers Rights 05/05/2017 by Intellectual Property Watch 1 Comment The right of farmers to use, exchange and sell farm-saved seeds should be ensured through national laws and a revision of the International Union for the Protection of New Varieties of Plants (UPOV), so the objectives of another United Nations international treaty on plant genetic resources can be fulfilled, a recent research paper states.
WIPO Promotes IP Flexibilities Database 05/05/2017 by Intellectual Property Watch Leave a Comment The UN World Intellectual Property Organization this week promoted a database it has developed containing a collection of flexibilities to IP laws in countries around the world.
TRIPS Flexibilities Under Threat From Investment Disputes: A Closer Look At Canada’s “Win” Against Eli Lilly 27/04/2017 by Intellectual Property Watch 3 Comments Cynthia Ho writes: In the first known investment dispute regarding patents, Eli Lilly & Co v. Canada, Canada recently prevailed over the pharmaceutical giant Eli Lilly. Although Canada won in a unanimous decision, the ruling does not, however, guarantee domestic discretion going forward, contrary to the suggestion of some.
‘Make Sure The Trademark Lawyer Is There’ At The Beginning 26/04/2017 by Peter Kenny for Intellectual Property Watch Leave a Comment For World Intellectual Property Day this year, the World Intellectual Property Organization held a discussion on “Innovation in Communication: A State of Mind,” with a creator designer, a brand consultant and a writer as the panel.
Licence For A New Hepatitis Treatment, With An Eye To Affordability 21/04/2017 by Intellectual Property Watch 2 Comments The Medicines Patent Pool has received a licence to develop ravidasvir, a new treatment for hepatitis C.
Civil Society-Led Monsanto Tribunal Finds Agro-Giant Guilty On All Counts 19/04/2017 by Catherine Saez, Intellectual Property Watch 1 Comment An international civil society tribunal has found that agro-business multinational Monsanto conducts activities that violate basic human rights. The five international judges of the Monsanto Tribunal presented their condemning verdict yesterday.
Google’s Waymo v. Uber Lawsuit Reflects High-Stakes IP War In Hot Driverless Car Sector 17/04/2017 by Bruce Gain for Intellectual Property Watch 2 Comments Google’s Waymo claims Uber, an app-based taxi service, stole technology for a critical component for driverless cars, as the one of the world’s most-powerful tech titans wages a fierce legal battle to protect its intellectual property in an emerging area of the automotive industry.
The Deepening Debate Over Vaccines And Antimicrobial Resistance Involves IP 12/04/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment With the looming threat of antimicrobial resistance (AMR), there is growing pressure to use vaccines because they obviate the need to prescribe antibiotics in the first place.
Hiring Freeze At USPTO Concerns Industry Groups 11/04/2017 by Intellectual Property Watch 3 Comments Members of the United States innovator business community have delivered a letter to President Trump requesting that the US Patent and Trademark Office be exempt from the federal hiring freeze announced in January.